TY  - JOUR
TT  - Can the Urologists Perform Stone Analysis, Metabolic Evaluation and  Metaphylaxis at Urinary Tract Stone Disease in Tekirdağ?
AU  - Akgül, Murat
AU  - Yazıcı, Cenk
AU  - Arda, Ersan
AU  - Akpınar, Haluk
PY  - 2019
DA  - September
DO  - 10.5798/dicletip.620323
JF  - Dicle Medical Journal
JO  - diclemedj
PB  - Dicle Üniversitesi
WT  - DergiPark
SN  - 1300-2945
SP  - 405
EP  - 410
VL  - 46
IS  - 3
LA  - en
KW  - Urinary system stone disease
KW  - metabolic evaluation
N2  - Objective: As the urolithiasis is an endemic situation in our country, the urologists are well-experienced about this situation. The prevention of urolithiasis recurrence is as important as the surgical treatment. For this reason metabolic evaluation and medical treatment of stone disease is extremely important. This study aimed to evaluate urological specialists' views of metabolic evaluation and medical treatment of urolithiasis. Thus, the main problems and the probable solutions about medical treatment and metabolic evaluation of urinary system stone disease can be evaluated.  Methods: The urologists working at Tekirdag were invited to the study. A face-to-face questionnaire, which was composed of three parts, was performed to the participants. In the first section, the demographic characteristics of the participants were evaluated. In the second and third sections, the approach of participants to metabolic evaluation and medical treatment in urolithiasis were investigated, respectively. Results: A total of 29 urologist who routinely performed endourological surgery were included to the study. When we evaluated their endourological practice, 65.5% of the participants were performing 10-25 endourological surgery per month. When we asked the approach of participants about the metabolic evaluation, 34.5% reported that they did not perform metabolic evaluation to their adult patients and 65.5% did not perform to the children with urolithiasis. All participants believed the efficacy of medical treatment however, 66% of the participants were performing at less than half of their patients in clinical practice. Conclusions: The clinical practice about metabolic evaluation, stone analysis and metaphylaxis were lower than expected. Most of the participants were not able to make metabolic evaluation and stone analysis. Further studies are needed to resolve the problems associated with metabolic evaluation and metaphylaxis administration. 
CR  - 1.	Akinci M, Esen T, Tellaloğlu S. Urinary stone disease in Turkey: an updated epidemiological study. Eur Urol. 1991; 20: 200-3.
CR  - 2.	Davarcı M, Rifaioğlu M, Yalçınkaya FR, et all. Üriner Sistem Taş Tedavisinde İki Senelik ESWL Sonuçlarının Değerlendirilmesi [Evaluation of the results of ESWL therapy in urinary system stone disease  for  two  years] Dicle Med J. 2012; 3: 377-380.
CR  - 3.	Amasyalı AS, Ertek MŞ, Türe M, et all. The Effect of Preoperative and Intraoperative Clinical Findings on Success of Endoscopic Management of Ureteral Stone Dicle Med J. 2016; 43: 285-9.
CR  - 4.	Celik H, Ediz C, Çamtosun A, et all. Percutaneous nephrolithotomy in very elderly patients (Age 75 and Over). Dicle Med J. 2015;42: 506-9.
CR  - 5.	Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12: 86-96.
CR  - 6.	Osman MM, Alfano Y, Kamp S, et all. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol. 2005;47: 860-4.
CR  - 7.	El-Nahas AR, El-Assmy AM, Madbouly K, et all. Predictors of clinical significance of residual fragments after extracorporeal shockwave lithotripsy for renal stones. J Endourol. 2006;20: 870-4.
CR  - 8.	Yuvanc E, Yilmaz E, Tuglu D, et all. Medical and alternative therapies in urinary tract stone disease. World J Nephrol. 2015; 6-4: 492-9.
CR  - 9.	Türk C, Neisius A, Petrik A, et all. EAU Guidelines on Urolithiasis. European Association of Urology 2017.
CR  - 10.	Gambaro G, Croppi E, Coe F, et all.(Consensus Conference Group) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29: 715-734.
CR  - 11.	Pearle MS, Goldfarb DS, Assimos DG, et all. Medical Management of Kidney Stones. American Urological Association 2014.
CR  - 12.	Ather H, Siddiqui I, Siddiqui T, et all. Tailored metabolic workup for urolithiasis–the debate continues. J Coll Physicians Surg Pak. 2017; 27: 101-4.
UR  - https://doi.org/10.5798/dicletip.620323
L1  - https://dergipark.org.tr/tr/download/article-file/808240
ER  -